FDA Drug recall D-0306-2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevar…
- FDA Drug
- Class III
- ongoing
- Published 2026-02-18
On 2026-02-18 the FDA classified a Class III recall of Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevar… by Unichem Pharmaceuticals Usa, citing tablets/Capsules Imprinted with Wrong ID.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0306-2026 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2026-01-21 |
| Published | 2026-02-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Unichem Pharmaceuticals Usa |
| Distribution | US |
Product
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Reason
Tablets/Capsules Imprinted with Wrong ID
Identifiers
| ndc | 29300-351-13 |
|---|---|
| ndc | 29300-351-01 |
| ndc | 29300-351-10 |
| ndc | 29300-352-13 |
| ndc | 29300-352-01 |
| ndc | 29300-352-10 |
| ndc | 29300-353-13 |
| ndc | 29300-353-01 |
| ndc | 29300-353-10 |
| ndc | 29300-354-13 |
| ndc | 29300-354-01 |
| ndc | 29300-354-10 |
| code_info | Lot # GDSH25006, Exp Date: 08/2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.